CoGenesys Manufacturing Capabilities

Development and manufacture of albumin-fusion products is rapid, predictable and reproducible, as both fermentation and purification procedures are based on the physicochemical properties of albumin. CoGenesys has a state-of-the-art development and manufacturing facility that is fully staffed and equipped to support both GLP development and cGMP manufacture of biologics. CoGenesys capabilities include production of recombinant proteins and monoclonal antibodies for early stage clinical studies, development labs, and QA/QC.